The girl died while infusion at the clinic

Ho Chi Minh CityA 28-year-old female patient was tired and feverish, entered a clinic in Binh Tan district, was diagnosed with dengue fever on the first day, gave intravenous fluids but suddenly stopped breathing and stopped breathing.

The patient was transferred to Thong Nhat Hospital on the evening of July 3. Associate Professor Le Dinh Thanh, director of the hospital, said the patient died before entering the hospital, the doctors tried to resuscitate but the patient did not survive.

“Usually, dengue fever is rarely fatal on the first day. Cerebrospinal fluid puncture results show that there is no blood clot, which can be highly suggestive of the possibility of brain hemorrhage due to rupture of cerebral vascular malformations,” Associate Professor Thanh said. , adding that the hospital has transferred the file to the investigating authorities to have an official conclusion on the cause of death.

A representative of the Ho Chi Minh City Department of Health said that he had received information about the case. Department Inspectors are coordinating with functional agencies to investigate and clarify the cause.

According to doctors, patients with dengue fever are not recommended to receive fluids, especially in the early days of the disease because of the risk of infusion shock or missing severe symptoms of the disease. However, when the patient has shock, low blood pressure, hemodynamic disturbances, etc., emergency fluids should be given at a medical facility under the supervision of medical staff.

In 2016, a 20-year-old female patient in Ho Chi Minh City entered a clinic because of fever, low blood pressure, was prescribed intravenous fluids, but her condition worsened and died. The results of the investigation later determined that the patient died from acute, severe and widespread myocarditis. This is a severe disease, progressing very quickly, with a very high mortality rate, and it is difficult to save lives if it is not detected early and treated promptly with artificial cardiopulmonary devices (ECMO).

Le Phuong


Leave a Reply

Your email address will not be published. Required fields are marked *